<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03896451</url>
  </required_header>
  <id_info>
    <org_study_id>PS vs. Sphere</org_study_id>
    <nct_id>NCT03896451</nct_id>
  </id_info>
  <brief_title>Comparison Between Two Total Knee Prosthesis Medacta GMK Sphere and Medacta GMK PS</brief_title>
  <official_title>Prospactive Randomized Monocentric Comparison Study Between Two Total Knee Prosthesis Medacta GMK Sphere and Medacta GMK PS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Winterthur KSW</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Winterthur KSW</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the clinical outcome after two total knee
      endoprosthesis designs Medacta GMK Sphere and Medacta GMK PS.

      Primary outcome measures KOOS, Forgotten Knee Score and range of motion.

      Single-center, randomized trial
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The clinical outcome measures were measured preoperativ and postoperativ (1 year, 5 year and
      10 year).

      Secondary outcome measures: number of reoperations and revisions, survival of the prosthesis

      The patient population would consist patients with knee osteoarthritis eligible for total
      knee replacement

      The aim of the study is to evaluate the effect of the knee prosthesis design on the patient
      outcome
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2031</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2031</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Knee injury and Osteoarthritis Outcome Score</measure>
    <time_frame>preoperative, 1 year, 5 year and 10 year after surgery</time_frame>
    <description>Knee injury and Osteoarthritis Outcome Score: 100 = maximum score, 0 = minimum score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Forgotten Joint Score</measure>
    <time_frame>1 year, 5 year and 10 year after surgery</time_frame>
    <description>Forgotten Joint Score: 100 = maximum score, 0 = minimum score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in revison</measure>
    <time_frame>1 year, 5 year and 10 year after surgery</time_frame>
    <description>Revision rate comparision with the baseline at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in range of motion</measure>
    <time_frame>preoperative, 1 year, 5 year and 10 year after surgery</time_frame>
    <description>Range of motion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>GMK Sphere</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients receiving total knee replacement surgery with the device &quot;Medacta GMK Sphere&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GMK PS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients receiving total knee replacement surgery with the device &quot;Medacta GMK PS&quot;</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Total knee endoprothesis</intervention_name>
    <description>Total knee endoprosthesis after knee joint osteoarthritis</description>
    <arm_group_label>GMK PS</arm_group_label>
    <arm_group_label>GMK Sphere</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient is eligible for a total knee replacement

          -  patient is eligible for a Medacta GMK Sphere or Medacta GMK PS knee prosthesis

          -  patient signed the informed consent

        Exclusion Criteria:

          -  patient is pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Koch, PD Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Principal Investigator</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Koch, PD Dr. med.</last_name>
    <phone>+41442662979</phone>
    <email>michel.schlaeppi@ksw.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michel Schlaeppi, MSc</last_name>
    <phone>+41442662996</phone>
    <email>michel.schlaeppi@ksw.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kantonsspital Winterthur</name>
      <address>
        <city>Winterthur</city>
        <state>Zurich</state>
        <zip>8400</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Schlaeppi, MSc</last_name>
      <phone>+41 52 266 29 79</phone>
      <email>michel.schlaeppi@ksw.ch</email>
    </contact>
    <contact_backup>
      <last_name>Peter Koch, PD Dr. med.</last_name>
      <phone>+41 52 266 29 96</phone>
      <email>peter.koch@ksw.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 26, 2019</study_first_submitted>
  <study_first_submitted_qc>March 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2019</study_first_posted>
  <last_update_submitted>March 28, 2019</last_update_submitted>
  <last_update_submitted_qc>March 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kantonsspital Winterthur KSW</investigator_affiliation>
    <investigator_full_name>Peter Koch</investigator_full_name>
    <investigator_title>Principal Investigator: PD/MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

